Dermatol. praxi. 2010;4(3):142-143
In dermatologic oncology an interferon alfa therapy is used most common in therapy of melanoma, then in therapy of sarcoma of Kaposi
and cutaneous T-cell lymphoma. The goal of this review is to provide an overview of the most common side effects of this therapy.
Published: November 20, 2010 Show citation
Go to PubMed...
Go to original source...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...